What does DR. LUC DE CLERCQ - REUMATOLOGIE do?

DR. LUC DE CLERCQ - REUMATOLOGIE is a specialist medical practice in Antwerpen. Private Limited, started on 19 April 2010, 1 establishment.

What is the address of DR. LUC DE CLERCQ - REUMATOLOGIE?

The registered office of DR. LUC DE CLERCQ - REUMATOLOGIE is located at Miraeusstraat 33, 2018 Antwerpen.

Is DR. LUC DE CLERCQ - REUMATOLOGIE still active?

Yes. According to the CBE (3 October 2026) DR. LUC DE CLERCQ - REUMATOLOGIE is active, legal situation “Normale toestand”, started on 19 April 2010.

Is DR. LUC DE CLERCQ - REUMATOLOGIE registered on Peppol?

Yes, DR. LUC DE CLERCQ - REUMATOLOGIE is registered on the Peppol network with ID 0208:0825195430.

What is the enterprise number of DR. LUC DE CLERCQ - REUMATOLOGIE?

The enterprise number of DR. LUC DE CLERCQ - REUMATOLOGIE is BE0825195430.

When was DR. LUC DE CLERCQ - REUMATOLOGIE founded?

DR. LUC DE CLERCQ - REUMATOLOGIE was founded on 19 April 2010.

Who are the directors of DR. LUC DE CLERCQ - REUMATOLOGIE?

According to the 2025 annual accounts, the directors of DR. LUC DE CLERCQ - REUMATOLOGIE are: Luc De Clercq.

Is DR. LUC DE CLERCQ - REUMATOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 April 2010; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. LUC DE CLERCQ - REUMATOLOGIE make in 2025?

DR. LUC DE CLERCQ - REUMATOLOGIE recorded a loss after taxes of € 10,702 in financial year 2025.

What is the revenue of DR. LUC DE CLERCQ - REUMATOLOGIE?

As a small company, DR. LUC DE CLERCQ - REUMATOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 40,695.

DR. LUC DE CLERCQ - REUMATOLOGIE (Private Limited)

Dossier DR. LUC DE CLERCQ - REUMATOLOGIE, printed on 3 October 2026 from databakkes.be/en/0825195430/dr-luc-de-clercq-reumatologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 16 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

DR. LUC DE CLERCQ - REUMATOLOGIE from Antwerpen, company number BE0825195430, closed financial year 2025 with a result of € -10,702 after tax. For that financial year DR. LUC DE CLERCQ - REUMATOLOGIE recorded a gross margin of € 40,695 and equity of € 18,421. Compared with financial year 2024, the result moved from € 3,046 to € -10,702. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.

What it is worth Growing

€ 18,421

▲ € 18,698 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -10,702

▼ still € 3,046 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 2,206

▲ € 2,073 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -10,979.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost

€ 39,186

▲ 5% vs 2024

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 195

▼ 97% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 5,607

▲ 18% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 7,959

▲ 3% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 37,297 Gross margin 2022: € 37,297 First fiscal year in the series	€ 36,992 Gross margin 2023: € 36,992 ▼ 1% vs 2022 (€ 37,297) Unfavourable step	€ 53,885 Gross margin 2024: € 53,885 ▲ 46% vs 2023 (€ 36,992) Favourable step	€ 40,695 Gross margin 2025: € 40,695 ▼ 24% vs 2024 (€ 53,885) Unfavourable step	▼ 24%
Profit after taxes	€ -3,206 Profit after taxes 2022: € -3,206 First fiscal year in the series	€ -5,734 Profit after taxes 2023: € -5,734 ▼ € 2,528 vs 2022 (€ -3,206) Unfavourable step	€ 3,046 Profit after taxes 2024: € 3,046 ▲ € 8,780 vs 2023 (€ -5,734) Favourable step	€ -10,702 Profit after taxes 2025: € -10,702 ▼ € 13,748 vs 2024 (€ 3,046) Unfavourable step	▼ € 13,748
Equity	€ 2,413 Equity 2022: € 2,413 First fiscal year in the series	€ -3,322 Equity 2023: € -3,322 ▼ € 5,735 vs 2022 (€ 2,413) Unfavourable step	€ -276 Equity 2024: € -276 ▲ € 3,046 vs 2023 (€ -3,322) Favourable step	€ 18,421 Equity 2025: € 18,421 ▲ € 18,698 vs 2024 (€ -276) Favourable step	▲ € 18,698
Total debts	€ 23,604 Total debts 2022: € 23,604 First fiscal year in the series	€ 36,138 Total debts 2023: € 36,138 ▲ 53% vs 2022 (€ 23,604) Unfavourable step	€ 40,392 Total debts 2024: € 40,392 ▲ 12% vs 2023 (€ 36,138) Unfavourable step	€ 14,190 Total debts 2025: € 14,190 ▼ 65% vs 2024 (€ 40,392) Favourable step	▼ 65%
Cash	€ 1,533 Cash 2022: € 1,533 First fiscal year in the series	€ 1,290 Cash 2023: € 1,290 ▼ 16% vs 2022 (€ 1,533) Unfavourable step	€ 133 Cash 2024: € 133 ▼ 90% vs 2023 (€ 1,290) Unfavourable step	€ 2,206 Cash 2025: € 2,206 ▲ € 2,073 vs 2024 (€ 133) Favourable step	▲ € 2,073
Retained profit	€ 2,413 Retained profit 2022: € 2,413 First fiscal year in the series	€ -3,322 Retained profit 2023: € -3,322 ▼ € 5,735 vs 2022 (€ 2,413) Unfavourable step	€ -276 Retained profit 2024: € -276 ▲ € 3,046 vs 2023 (€ -3,322) Favourable step	€ -10,979 Retained profit 2025: € -10,979 ▼ € 10,702 vs 2024 (€ -276) Unfavourable step	▼ € 10,702
Balance sheet total	€ 26,017 Balance sheet total 2022: € 26,017 First fiscal year in the series	€ 32,816 Balance sheet total 2023: € 32,816 ▲ 26% vs 2022 (€ 26,017) Unchanged	€ 40,116 Balance sheet total 2024: € 40,116 ▲ 22% vs 2023 (€ 32,816) Unchanged	€ 32,611 Balance sheet total 2025: € 32,611 ▼ 19% vs 2024 (€ 40,116) Unchanged	▼ 19%

Key figures of DR. LUC DE CLERCQ - REUMATOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. LUC DE CLERCQ - REUMATOLOGIE?

What happened at DR. LUC DE CLERCQ - REUMATOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 29, 2026 New annual accounts for financial year 2025: loss of € 10,702 (▼ € 13,748 vs 2024). Source: NBB ↗
May 1, 2010 New establishment in Antwerpen. KBO
2010 Luc De Clercq became a director. NBB
Apr 19, 2010 Start of the company according to the CBE. KBO

In short

From € 3,206 loss in 2022 to € 10,702 loss in 2025.

Paid € 1,095 in corporate taxes since 2022.

Best year ever: 2024, with € 3,046 profit.

Original PDFs at the National Bank ↗

A new publication or filing at DR. LUC DE CLERCQ - REUMATOLOGIE? We notify you, reason included.

Follow DR. LUC DE CLERCQ - REUMATOLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Luc De Clercq

DR. LUC DE CLERCQ - REUMATOLOGIE

Behind DR. LUC DE CLERCQ - REUMATOLOGIE is Luc De Clercq.

See the full network in the app

Directors

According to the 2025 annual accounts

Luc De Clercq

Director

since 2010

Establishments

Establishment units

Physical locations of this company

Registered office

Miraeusstraat 33

2018 Antwerpen

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

DOKTER LUCAS VERKINDEREN

€ 213,323 gross margin · 2025

Vereniging van mede-eigenaars van het gebouw te 2018 Antwerpen, Miraeusstraat 33

Lukas De Graeve

€ 145,838 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0825.195.430
VAT number: BE 0825.195.430
Registered office: Miraeusstraat 33, 2018 Antwerpen
Names & denominations: DR. LUC DE CLERCQ - REUMATOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 19 April 2010
Peppol: Active · Active since 27 Mar 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗